Aisha Amin, MD
Internal Medicine · Sunnyvale
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: 757662 · El Camino Health. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Amin’s office at (408) 739-6000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A169657 · Current
Licensed to practise in California · since 2020 · expires 2028-08-31 · Ziauddin University, Ziauddin Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$36,697
Medicare paid this office $36,697 for 174 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 84 | $14,191 | $112 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 62 | $9,773 | $158 |
| Short return visit (20+ min) | 58 | $4,682 | $77 |
Who their Medicare patients are
174 Original Medicare patients in 2024. Average age 74 · Under 65 7% · 85 and older 15% · Women 62% · Also on Medicaid 9% · Health risk score 1.01. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 57% · Diabetes 24% · Chronic kidney disease 21% · Coronary heart disease 18% · Atrial fibrillation 18% · Depression 16% · Cancer 12% · Heart failure 10% · Dementia 10% · COPD 7% · Stroke 6%.
The office billed $97,579, Medicare allowed $45,498 and paid $36,697; for 323 services of 29 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 174 | 323 | 74 | 1.01 | $97,579 | $36,697 |
| 2023 | 177 | 313 | 76 | 1.24 | $90,290 | $33,306 |
| 2022 | 248 | 526 | 76 | 0.98 | $133,847 | $52,589 |
| 2021 | 129 | 305 | 75 | 0.90 | $69,755 | $25,873 |
| 2020 | 34 | 50 | 77 | 0.74 | $11,919 | $3,815 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Return visit (30+ min) | 88 | $11,779 | $104 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 49 | $7,817 | $160 |
| Short return visit (20+ min) | 74 | $6,326 | $68 |
2022: 7 services
| Return visit (30+ min) | 110 | $17,487 | $120 |
| Short return visit (20+ min) | 138 | $16,135 | $74 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 64 | $10,133 | $158 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 12 | $1,083 | $90 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 13 | $913 | $70 |
| Administration of influenza virus vaccine | 15 | $567 | $38 |
| Administration of pneumococcal vaccine | 12 | $409 | $34 |
2021: 7 services
| Short return visit (20+ min) | 92 | $11,037 | $78 |
| Return visit (30+ min) | 44 | $5,245 | $99 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 17 | $2,448 | $144 |
| Pneumococcal vaccine, 23-valent | 11 | $1,373 | $125 |
| Influenza vaccine split virus, preservative free | 17 | $1,109 | $65 |
| Administration of influenza virus vaccine | 17 | $367 | $22 |
| Administration of pneumococcal vaccine | 11 | $236 | $21 |
2020: 1 service
| Short return visit (20+ min) | 21 | $1,925 | $74 |
Drugs they prescribed that Part D paid
$160,629
Pharmacies billed $160,629 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (43 of 1,917) in 2024. Above the middle of the specialty; the typical internal medicine clinician is at 1%.
1,666 generic and 235 brand-name prescriptions · $160,629 in drug cost · 34 antibiotic prescriptions to 27 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 25 | $41,002 | $1,640 |
| Farxiga | 11 | $12,510 | $1,137 |
| Anoro Ellipta | 12 | $4,389 | $366 |
| Estradiol | 15 | $1,495 | $100 |
| Atorvastatin | 185 | $1,361 | $7 |
See all 45 drugs
| Eliquis | 25 | $41,002 | $1,640 |
| Farxiga | 11 | $12,510 | $1,137 |
| Anoro Ellipta | 12 | $4,389 | $366 |
| Estradiol | 15 | $1,495 | $100 |
| Atorvastatin | 185 | $1,361 | $7 |
| Levoxyl | 17 | $877 | $52 |
| Tamsulosin | 38 | $771 | $20 |
| Levalbuterol Tartrate Hfa | 13 | $711 | $55 |
| Amlodipine Besylate | 91 | $707 | $8 |
| Hydrocodone-Acetaminophen | 38 | $702 | $18 |
| Levothyroxine | 55 | $698 | $13 |
| Gabapentin | 47 | $691 | $15 |
| Olanzapine | 30 | $653 | $22 |
| Losartan | 65 | $574 | $9 |
| Omeprazole | 35 | $558 | $16 |
| Lisinopril | 67 | $498 | $7 |
| Metoprolol | 41 | $490 | $12 |
| Synthroid | 18 | $457 | $25 |
| Citalopram Hbr | 66 | $417 | $6 |
| Alendronate | 44 | $372 | $8 |
| Glipizide Er | 24 | $348 | $14 |
| Propranolol | 12 | $338 | $28 |
| Metformin | 46 | $292 | $6 |
| Atenolol | 18 | $283 | $16 |
| Venlafaxine Hcl Er | 12 | $269 | $22 |
| Hydrochlorothiazide | 29 | $242 | $8 |
| Fluoxetine | 21 | $241 | $11 |
| Zolpidem | 34 | $238 | $7 |
| Ezetimibe | 13 | $220 | $17 |
| Bupropion Xl | 17 | $212 | $12 |
| Albuterol Sulfate Hfa | 15 | $206 | $14 |
| Sertraline | 13 | $191 | $15 |
| Allopurinol | 16 | $167 | $10 |
| Doxazosin Mesylate | 12 | $160 | $13 |
| Pravastatin | 12 | $158 | $13 |
| Clonidine | 13 | $155 | $12 |
| Simvastatin | 26 | $141 | $5 |
| Losartan-Hydrochlorothiazide | 23 | $138 | $6 |
| Cyclobenzaprine | 21 | $128 | $6 |
| Ondansetron Odt | 12 | $94 | $8 |
| Metformin Hcl Er | 15 | $80 | $5 |
| Furosemide | 14 | $77 | $5 |
| Lisinopril-Hydrochlorothiazide | 16 | $66 | $4 |
| Alprazolam | 12 | $55 | $5 |
| Carvedilol | 11 | $34 | $3 |
Year by year
| 2024 | 1,917 | 188 | 2% (43) | 12% | $160,629 |
| 2023 | 2,057 | 209 | 3% (62) | 12% | $162,972 |
| 2022 | 1,990 | 236 | 4% (73) | 13% | $172,139 |
| 2021 | 1,086 | 148 | 3% (35) | 14% | $90,387 |
| 2020 | 149 | 53 | None | None | $31,203 |
| 2019 | 142 | 47 | 0% (0) | None | $8,591 |
| 2018 | 222 | 48 | None | None | $38,755 |
| 2017 | 27 | 14 | 0% (0) | None | $1,073 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 47 drugs
| Eliquis | 29 | $36,176 | $1,247 |
| Ozempic | 11 | $13,960 | $1,269 |
| Anoro Ellipta | 12 | $6,096 | $508 |
| Atorvastatin | 195 | $2,174 | $11 |
| Olanzapine | 21 | $1,561 | $74 |
| Tamsulosin | 49 | $1,266 | $26 |
| Propranolol | 14 | $956 | $68 |
| Metoprolol | 64 | $911 | $14 |
| Levothyroxine | 74 | $889 | $12 |
| Levalbuterol Tartrate Hfa | 16 | $865 | $54 |
| Hydrocodone-Acetaminophen | 44 | $811 | $18 |
| Metformin | 59 | $718 | $12 |
| Gabapentin | 33 | $675 | $20 |
| Omeprazole | 37 | $664 | $18 |
| Amlodipine Besylate | 93 | $661 | $7 |
| Losartan | 61 | $661 | $11 |
| Lisinopril | 78 | $661 | $8 |
| Alendronate | 33 | $522 | $16 |
| Duloxetine | 20 | $452 | $23 |
| Citalopram Hbr | 47 | $413 | $9 |
| Lorazepam | 27 | $412 | $15 |
| Cyclobenzaprine | 35 | $368 | $11 |
| Glipizide Er | 17 | $335 | $20 |
| Fluticasone Propionate | 18 | $298 | $17 |
| Pravastatin | 16 | $295 | $18 |
| Pantoprazole | 18 | $294 | $16 |
| Losartan-Hydrochlorothiazide | 21 | $269 | $13 |
| Carvedilol | 11 | $263 | $24 |
| Paroxetine | 19 | $248 | $13 |
| Allopurinol | 17 | $225 | $13 |
| Furosemide | 22 | $220 | $10 |
| Hydrochlorothiazide | 22 | $216 | $10 |
| Sertraline | 24 | $207 | $9 |
| Ezetimibe | 14 | $207 | $15 |
| Fluoxetine | 20 | $179 | $9 |
| Zolpidem | 33 | $173 | $5 |
| Simvastatin | 23 | $169 | $7 |
| Clonidine | 16 | $162 | $10 |
| Atenolol | 26 | $158 | $6 |
| Nitrofurantoin Mono-Macro | 12 | $149 | $12 |
| Paxlovid (Eua) | 13 | $140 | $11 |
| Lisinopril-Hydrochlorothiazide | 16 | $126 | $8 |
| Metoprolol | 13 | $122 | $9 |
| Trazodone | 12 | $95 | $8 |
| Metformin Hcl Er | 12 | $92 | $8 |
| Alprazolam | 18 | $46 | $3 |
| Ondansetron | 12 | $45 | $4 |
2022: 51 drugs
| Eliquis | 17 | $24,205 | $1,424 |
| Farxiga | 15 | $21,724 | $1,448 |
| Novolog Mix 70-30 | 14 | $13,649 | $975 |
| Oxycontin | 11 | $5,950 | $541 |
| Lantus Solostar | 13 | $4,763 | $366 |
| Atorvastatin | 168 | $2,360 | $14 |
| Tamsulosin | 51 | $1,683 | $33 |
| Pantoprazole | 24 | $1,560 | $65 |
| Gabapentin | 43 | $1,136 | $26 |
| Olanzapine | 21 | $1,135 | $54 |
| Levothyroxine | 63 | $1,078 | $17 |
| Albuterol Sulfate Hfa | 23 | $1,031 | $45 |
| Metoprolol | 47 | $942 | $20 |
| Venlafaxine Hcl Er | 12 | $816 | $68 |
| Ultra-Fine Mini Pen Needle | 14 | $762 | $54 |
| Amlodipine Besylate | 87 | $759 | $9 |
| Dilt-Xr | 11 | $568 | $52 |
| Losartan | 61 | $536 | $9 |
| Omeprazole | 35 | $529 | $15 |
| Chlorthalidone | 15 | $525 | $35 |
| Duloxetine | 18 | $519 | $29 |
| Alendronate | 37 | $517 | $14 |
| Metformin | 59 | $506 | $9 |
| Simvastatin | 25 | $477 | $19 |
| Hydrocodone-Acetaminophen | 31 | $460 | $15 |
| Cyclobenzaprine | 15 | $456 | $30 |
| Lisinopril | 67 | $409 | $6 |
| Lorazepam | 34 | $329 | $10 |
| Allopurinol | 14 | $286 | $20 |
| Ketoconazole | 12 | $271 | $23 |
| Trazodone | 16 | $255 | $16 |
| Carvedilol | 16 | $214 | $13 |
| Fluoxetine | 18 | $207 | $12 |
| Paroxetine | 13 | $193 | $15 |
| Temazepam | 12 | $192 | $16 |
| Clonazepam | 11 | $170 | $15 |
| Furosemide | 25 | $169 | $7 |
| Clonidine | 17 | $160 | $9 |
| Atenolol | 27 | $160 | $6 |
| Citalopram Hbr | 23 | $157 | $7 |
| Paxlovid (Eua) | 16 | $156 | $10 |
| Cephalexin | 17 | $152 | $9 |
| Hydrochlorothiazide | 20 | $150 | $7 |
| Fluticasone Propionate | 15 | $146 | $10 |
| Losartan-Hydrochlorothiazide | 14 | $128 | $9 |
| Glipizide | 11 | $113 | $10 |
| Sertraline | 12 | $88 | $7 |
| Lisinopril-Hydrochlorothiazide | 19 | $86 | $5 |
| Zolpidem | 22 | $83 | $4 |
| Alprazolam | 17 | $64 | $4 |
| Tramadol | 21 | $50 | $2 |
2021: 26 drugs
| Advair Diskus | 16 | $7,124 | $445 |
| Atorvastatin | 94 | $1,960 | $21 |
| Tamsulosin | 27 | $919 | $34 |
| Levothyroxine | 46 | $904 | $20 |
| Gabapentin | 37 | $801 | $22 |
| Metoprolol | 25 | $630 | $25 |
| Amlodipine Besylate | 57 | $513 | $9 |
| Omeprazole | 18 | $385 | $21 |
| Metformin | 36 | $377 | $10 |
| Lisinopril | 39 | $317 | $8 |
| Pantoprazole | 11 | $297 | $27 |
| Doxazosin Mesylate | 14 | $273 | $19 |
| Losartan | 24 | $243 | $10 |
| Allopurinol | 15 | $241 | $16 |
| Hydrocodone-Acetaminophen | 14 | $234 | $17 |
| Trazodone | 18 | $211 | $12 |
| Alendronate | 20 | $181 | $9 |
| Furosemide | 18 | $175 | $10 |
| Atenolol | 14 | $165 | $12 |
| Clonidine | 15 | $145 | $10 |
| Citalopram Hbr | 13 | $140 | $11 |
| Tramadol | 16 | $122 | $8 |
| Quetiapine | 11 | $108 | $10 |
| Lisinopril-Hydrochlorothiazide | 13 | $93 | $7 |
| Hydrochlorothiazide | 16 | $77 | $5 |
| Fluoxetine | 12 | $74 | $6 |
2018: 4 drugs
| Azelastine | 11 | $226 | $21 |
| Atorvastatin | 22 | $168 | $8 |
| Lisinopril | 22 | $76 | $3 |
| Metoprolol | 11 | $57 | $5 |
Professional record
- NPI
- 1013440981
- Licence
- CA A169657California A169657: Current · expires 2028-08-31
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2017-04-07
- NPI last updated
- 2020-09-28
- NPI record certified
- 2020-09-28
This is when the NPI record was last certified, not a medical board exam.